Holen Sie sich die Stockscreener-App
4.47
3.25%
-0.15
Handel nachbörslich:
4.47
Hcw Biologics Inc Aktie (HCWB) Neueste Nachrichten
MSN Money - MSN
HCW Biologics (HCWB) clears $2.8M disputes and $1.1M lien - Stock Titan
HCW Biologics Inc.: Top Mutual Funds Holders | QNCX | US40423R3030 - marketscreener.com
HCW Biologics Inc.: Fundamental Analysis and Financial Ratings | QNCX | US40423R3030 - marketscreener.com
HCW Biologics Inc.: Dividend historical data and projections - marketscreener.com
HCW Biologics regains Nasdaq compliance, plans stock split - Investing.com UK
HCW Biologics to Implement 1-for-6 Reverse Stock Split - Moomoo
HCW Biologics regains Nasdaq compliance, plans stock split By Investing.com - Investing.com Nigeria
HCW Biologics (NASDAQ: HCWB) regains bid-price compliance and sets 1-for-6 reverse split - Stock Titan
HCW Biologics Regains Nasdaq Bid Price Compliance and Announces 1-for-6 Reverse Stock Split - Quiver Quantitative
HCW Biologics clears Nasdaq bid-price rule, then splits stock 1-for-6 - Stock Titan
HCW BIOL: Target Price Consensus and Analysts Recommendations | HCWB | US40423R2040 - marketscreener.com
symbol__ Stock Quote Price and Forecast - CNN
HCW Biologics Inc (HCWB) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
HCW Biologics executes 1-for-6 reverse stock split for Nasdaq By Investing.com - Investing.com Australia
HCW Biologics Inc (HCWB) Stock Price, Quote, News & History - Benzinga
HCW Biologics' Reverse Split: A Calculated Gamble to Secure Its Future - BriefGlance
HCW Biologics executes 1-for-6 reverse stock split for Nasdaq - Investing.com
HCW Biologics Announces 1-for-6 Reverse Stock Split to Maintain Nasdaq Listing Compliance Effective June 30, 2026 - Minichart
HCW Biologics Announces 1-for-6 Reverse Stock Split - TipRanks
HCW Biologics (NASDAQ: HCWB) enacts 1-for-6 reverse split to support Nasdaq bid-price compliance - Stock Titan
HCW Biologics Announces 1-for-6 Reverse Stock Split Effective on June 30, 2026 - GlobeNewswire
HCW Biologics Inc (HCWB) Valuation: PE, PB & Fair Value Analysis - TradingKey
HCW Biologics, Inc. Actuals & Estimates (NASDAQ:HCWB) - TradingView
HCW Biologics Inc (HCWB) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
[EFFECT] HCW Biologics Inc. SEC Filing - Stock Titan
HCW Biologics Inc (HCWB) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
HCW Biologics Inc (HCWB) Institutional Confidence - TradingKey
HCW Biologics (HCWB) files exhibits-only S-1 amendment with new exhibits - Stock Titan
HCW Biologics Inc (HCWB) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
HCW Biologics Inc (HCWB) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
HCW Biologics Inc (HCWB) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
HCW Biologics Inc (HCWB) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
HCW Biologics Shareholders Approve Governance and Capital Measures - The Globe and Mail
HCW Biologics takes back rights to commercial-ready reagents - MSN
HCW Biologics reports positive early alopecia trial data - grafa.com
What's Going On With HCW Biologics Stock Tuesday?HCW Biologics (NASDAQ:HCWB) - Benzinga
HCWB: Preliminary Results from HCW Biologics' Phase 1 Trial Show Promising Data - GuruFocus
HCW Biologics reports positive early data for autoimmune drug By Investing.com - Investing.com Australia
HCW Biologics reports positive early data for autoimmune drug - Investing.com
HCW Biologics Announces Positive Results for Preliminary - GlobeNewswire
HCW Biologics Inc. Files Form 8-K with SEC Detailing Company and Stock Information - Minichart
HCW Biologics (HCWB) AGM 2026 Summary - Quartr
Shareholders back HCW Biologics (NASDAQ: HCWB) 2026 board slate - Stock Titan
HCW Biologics (HCWB) Slides to $1.28 as Selling Pressure PersistsIV Contraction - dars.gov.et
HCW Biologics Inc Stock Short Interest Rises to 58.43% - Quiver Quantitative
HCWB Announces Selling Shareholder Plans for 5.69M Shares - GuruFocus
HCW Biologics Registers Resale of Up to 5.7 Million Shares - marketscreener.com
HCW Biologics Proposed Resale Of Up To 5.69 Million Shares Of Common Stock - TradingView
1.17%
2.48%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):